ID :
22336
Thu, 10/02/2008 - 13:35
Auther :

Novartis to invest US$20 mln in S. Korea

SEOUL, Oct. 2 (Yonhap) -- Novartis AG, Switzerland's No. 2 drugmaker, said Thursday it plans to invest US$20 million in South Korea over the next five years to promote innovation in the nation's biotechnology sector.

As part of the investment plan, Novartis has signed a contract to buy an
unspecified amount of stake in a local cancer-treatment start-up named Neomix for
$1 million, the company's Korean unit said in a statement.

X